High-resolution scintimammography: a pilot study.

UNLABELLED This study evaluated a novel high-resolution breast-specific gamma camera (HRBGC) for the detection of suggestive breast lesions. METHODS Fifty patients (with 58 breast lesions) for whom a scintimammogram was clinically indicated were prospectively evaluated with a general-purpose gamma camera and a novel HRBGC prototype. The results of conventional and high-resolution nuclear studies were prospectively classified as negative (normal or benign) or positive (suggestive or malignant) by 2 radiologists who were unaware of the mammographic and histologic results. All of the included lesions were confirmed by pathology. RESULTS There were 30 benign and 28 malignant lesions. The sensitivity for detection of breast cancer was 64.3% (18/28) with the conventional camera and 78.6% (22/28) with the HRBGC. The specificity with both systems was 93.3% (28/30). For the 18 nonpalpable lesions, sensitivity was 55.5% (10/18) and 72.2% (13/18) with the general-purpose camera and the HRBGC, respectively. For lesions < or = 1 cm, 7 of 15 were detected with the general-purpose camera and 10 of 15 with the HRBGC. Four lesions (median size, 8.5 mm) were detected only with the HRBGC and were missed by the conventional camera. CONCLUSION Evaluation of indeterminate breast lesions with an HRBGC results in improved sensitivity for the detection of cancer, with greater improvement shown for nonpalpable and < or =1-cm lesions.

[1]  Francesco Scopinaro,et al.  High-resolution scintimammography improves the accuracy of technetium-99m methoxyisobutylisonitrile scintimammography: use of a new dedicated gamma camera , 1999, European Journal of Nuclear Medicine.

[2]  I. Mena,et al.  Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma. , 1995, Radiology.

[3]  B. Welch,et al.  Optimization of dedicated scintimammography procedure using detector prototypes and compressible phantoms , 2000 .

[4]  Francesco Scopinaro,et al.  Multi-PSPMT scintillating camera , 1997 .

[5]  Z. Burak,et al.  Evaluation of palpable breast masses with 99Tcm‐MIBI: a comparative study with mammography and ultrasonography , 1994, Nuclear medicine communications.

[6]  T Leitha,et al.  Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99m sestamibi scintimammography. , 1997, Radiology.

[7]  A. Robidoux,et al.  Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  W. Moses,et al.  A discrete scintillation camera module using silicon photodiode readout of CsI(TI) crystals for breast cancer imaging , 1998 .

[9]  M. Greco,et al.  Prone scintimammography in patients with non-palpable breast lesions. , 1996, Anticancer research.

[10]  J. Sandbank,et al.  Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  B. Welch,et al.  Optimization of dedicated scintimammography procedure using detector prototypes and compressible phantoms , 2000, 2000 IEEE Nuclear Science Symposium. Conference Record (Cat. No.00CH37149).

[12]  J. Maublant,et al.  Scintimammography with technetium-99m methoxyisobutylisonitrile: results of a prospective European multicentre trial , 1998, European Journal of Nuclear Medicine.

[13]  E. Clifford,et al.  Scintimammography in the diagnosis of breast cancer. , 1996, American journal of surgery.

[14]  I. Khalkhali,et al.  Scintimammographic analysis of nonpalpable breast lesions previously identified by conventional mammography. , 1998, Journal of the National Cancer Institute.

[15]  Shuu-Jiun Wang,et al.  The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses , 1994, European Journal of Nuclear Medicine.

[16]  G De Vincentis,et al.  A three center study on the diagnostic accuracy of 99mTc-MIBI scintimammography. , 1997, Anticancer research.

[17]  J. Villanueva-Meyer,et al.  Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  I. Mena,et al.  Prone scintimammography in patients with suspicion of carcinoma of the breast. , 1994, Journal of the American College of Surgeons.

[19]  S. Ilgan,et al.  99Tcm-MIBI scintimammography in the evaluation of breast lesions and axillary involvement: a comparison with mammography and histopathological diagnosis. , 1999, Nuclear medicine communications.

[20]  R. Orda,et al.  99Tcm-MIBI scintimammography for the detection of breast malignancies: the contribution of the count ratio to specificity. , 1999, Nuclear medicine communications.

[21]  R. Tiling,et al.  Role of technetium-99m sestamibi scintimammography and contrast-enhanced magnetic resonance imaging for the evaluation of indeterminate mammograms , 1997, European Journal of Nuclear Medicine.

[22]  R. Pani,et al.  Single tube gamma camera for scintimammography. , 1997, Anticancer research.

[23]  F. Iacopi,et al.  99mTc-MIBI scintimammography using a dedicated nuclear mammograph. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  G. de Vincentis,et al.  99mTc-MIBI prone scintimammography in patients with high and intermediate risk mammography. , 1997, Anticancer research.

[25]  C A Kelsey,et al.  Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico. , 1998, Radiology.